{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:05:10Z","timestamp":1792019110114,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1080\/14653240802549470","type":"journal-article","created":{"date-parts":[[2008,11,15]],"date-time":"2008-11-15T07:59:35Z","timestamp":1226735975000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up"],"prefix":"10.1016","volume":"11","author":[{"given":"H.","family":"Deda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mc","family":"Inci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ae","family":"K\u00fcrek\u00e7i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kay\u0131han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"\u00d6zg\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"\u00dcst\u00fcnsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kocabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1080\/14653240802549470_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406010854","article-title":"Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment","volume":"8","author":"Goodall","year":"2006","journal-title":"Expert Rev Mol Med"},{"key":"10.1080\/14653240802549470_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","article-title":"A controlled trial of riluzon in amyotrophic lateral sclerosis. ALS\/Riluzon Study Group","volume":"330","author":"Bensimon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1080\/14653240802549470_bib0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(04)16634-8","article-title":"Stem-cell therapy for amyotrophic lateral sclerosis","volume":"364","author":"Silani","year":"2004","journal-title":"Lancet"},{"key":"10.1080\/14653240802549470_bib0020","first-page":"21","article-title":"The potential for the use of mononuclear cells from human umblical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice","volume":"31","author":"Chen","year":"2000","journal-title":"J Med"},{"issue":"suppl 1","key":"10.1080\/14653240802549470_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/17434470410020814","article-title":"Summing up: an action plan for ALS research","volume":"5","author":"Rowland","year":"2004","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1080\/14653240802549470_bib0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567202043362243","article-title":"Cell-replacement therapy with stem cells in neurodegenerative disease","volume":"1","author":"Silani","year":"2004","journal-title":"Curr Neurovasc Res"},{"key":"10.1080\/14653240802549470_bib0035","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","article-title":"Unraveling the mechanisms involved in motor neuron degeneration in ALS","volume":"27","author":"Brujin","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"10.1080\/14653240802549470_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jcp.20959","article-title":"From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells","volume":"211","author":"Giardano","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1080\/14653240802549470_bib0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1146\/annurev.neuro.27.070203.144244","article-title":"Unraveling the mechanisms involved in motor neuron degeneration in ALS","volume":"27","author":"Bruijn","year":"2004","journal-title":"Annu Rev Neurosci"},{"key":"10.1080\/14653240802549470_bib0050","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/01.wco.0000187248.21103.c5","article-title":"Amyotrophic lateral sclerosis: recent advances and future therapies","volume":"18","author":"Nirmalananthan","year":"2005","journal-title":"Curr Opin Neurol"},{"key":"10.1080\/14653240802549470_bib0055","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbadis.2006.06.004","article-title":"Cellular therapies in motor neuron diseases","volume":"1762","author":"Nayak","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1080\/14653240802549470_bib0060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Jlang","year":"2002","journal-title":"Nature"},{"key":"10.1080\/14653240802549470_bib0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/152581603321210109","article-title":"Fetal human hematopoietic stem cells can differentiate sequentially into neural stem cells and then astrocytes in vitro","volume":"12","author":"Hao","year":"2003","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1080\/14653240802549470_bib0070","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1089\/152581601317211015","article-title":"Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis","volume":"10","author":"Janson","year":"2001","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1080\/14653240802549470_bib0075","first-page":"133","article-title":"Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans","volume":"4","author":"Mazzini","year":"2003","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1080\/14653240802549470_bib0080","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(04)17470-9","article-title":"Stem-cell therapy in amyotrophic lateral sclerosis","volume":"364","author":"Mazzini","year":"2004","journal-title":"Lancet"},{"key":"10.1080\/14653240802549470_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1179\/016164106X116791","article-title":"Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis","volume":"28","author":"Mazzini","year":"2006","journal-title":"Neurol Res"},{"key":"10.1080\/14653240802549470_bib0090","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mus.10191","article-title":"Inflammatory processes in amyotrophic lateral sclerosis","volume":"26","author":"McGeer","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1080\/14653240802549470_bib0095","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/glia.20210","article-title":"Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis","volume":"51","author":"Sargsyan","year":"2005","journal-title":"Glia"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324909702440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324909702440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:12:01Z","timestamp":1761430321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324909702440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"alternative-id":["S1465324909702440"],"URL":"https:\/\/doi.org\/10.1080\/14653240802549470","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1080\/14653240802549470","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}